In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Gladstone Foundation
The Gladstone Foundation is a nonprofit organization that provides financial and advisory support to Gladstone Institutes. Established in 2011, this volunteer organization is composed of dedicated leaders who understand that the search for global cures must begin with deep biological knowledge and research.
Board of Directors
Chair
William H. Younger, Jr.Retired Managing DirectorSutter Hill Ventures
Vice Chair
Stasia A. ObremskeyManaging DirectorRhia VenturesBoard Members
Chris Boskin
Media ConsultantKen Coit
Owner, Coit Financial GroupFred Craves, PhD
Founder and Managing Director, Bay City CapitalMarianne De Backer, PhD, MBA
CEO and Director, Vir Biotechnology, Inc.William Evers
Managing Director, AlTi GlobalSakurako D. Fisher
Former President, San Francisco SymphonyLinda Grais, MD, JD
Former President and CEO, Ocera TherapeuticsErin Hoffmann
President and Co-Founder, Additional VenturesLi Lu
Founder and Chairman, Himalaya CapitalDiksha Makan
Senior Vice President of Technology Strategy, ICONIQ CapitalGary Morgenthaler
Partner, Morgenthaler VenturesDeep V. Nishar
Managing Director, General CatalystDenise O’Leary
Former General Partner, Menlo VenturesSteve Richardson
Consultant, Executive Management, Alexandria Real Estate Equities, Inc.Douglas G. Scrivner
Retired General Counsel, AccentureDeepak Srivastava, MD
President, Gladstone Institutes Director, Roddenberry Stem Cell CenterR. Sanders Williams, MD
President Emeritus, Gladstone Institutes
Board Officers
Michelle Sibly
TreasurerRobert Wicks
CEO
Latest News
Read
Gladstone Institutes Launches Redesigned Website, Bringing Cutting-Edge Biomedical Research Into Focus
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
Read
Newly Discovered Antiviral System in Bacteria Is ‘Strangest of Its Kind’
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Read
Gladstone’s Seth Shipman Named Fellow of the California Academy of Sciences
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Read
Novel Biosensor Uses DNA ‘Barcodes’ to Uncover Disease Signals in Cells
Inspired by bacterial biology, the Gladstone-developed “Detectron” opens up new possibilities for disease research and potentially treatments.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now